First-time endoscopy and use of antisecretory medication: A population-based cohort study

Scandinavian Journal of Gastroenterology

Volumn 40, Issue 6, 2005, Pages 705-712

  Lassen, Annmarie ^a   Hallas, Jesper ^a   De Muckadell, Ove B Schaffalitzky ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Anti ulcer; Cohort study; Endoscopy; Medication; Oesophagitis; Peptic ulcer

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR; STOMACH SECRETION INHIBITOR;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DIAGNOSTIC PROCEDURE; DOSE RESPONSE; ESOPHAGITIS; EVALUATION; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL;

ADULT; AGED; ANTI-ULCER AGENTS; COHORT STUDIES; CONFIDENCE INTERVALS; DENMARK; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GASTROSCOPY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEPTIC ULCER; PROTON PUMPS; REGISTRIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 20444479414     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520510015476     Document Type: Article

References (27)

1. Lægemiddelstatistik 1998-2002 Danmark. København: Lægemiddelstyrelsen; 2003.
2. Bashford JN, Norwood J, Chapman SR. Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database. Br Med J 1998;317:452-6.
3. Westbrook JI, Duggan AE, McIntosh JH. Prescriptions for antiulcer drugs in Australia: volume, trends, and costs. Br Med J 2001;323:1338-9.
4. Talley NJ. Dyspepsia: management guidelines for the millennium. Gut 2002;50 Suppl 4:72-8.
5. Talley NJ, Silverstein MD, Agreus L, Nyren O, Sonnenberg A, Holtmann G. AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology 1998;114:582-95.
6. 2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet 1994;343:811-6.
7. Delaney BC, Wilson S, Roalfe A, Roberts L, Redman V, Wearn A, et al. Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: a randomised controlled trial in primary care. Lancet 2000;356:1965-9.
8. Gaist D, Sorensen HT, Hallas J. The Danish prescription registries. Dan Med Bull 1997;44:445-8.
9. Classification index including defined daily doses (DDD) for plain substances. WHO collaborating center for drug statistical methodology 1995. Oslo, Norway.
10. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999;46:263-8.
11. Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry: history, content, quality and use. Dan Med Bull 1997;44:535-9.
12. Frank L. Epidemiology. When an entire country is a cohort. Science 2000;287:2398-9.
13. Altman D. Practical statistics for medical research. Chapman & Hall, London: UK; 1991.
14. Schwartz LM, Woloshin S, Welch HG. Trends in diagnostic testing following a national guideline for evaluation of dyspepsia. Arch Intern Med 1996;156:873-5.
15. Scott BB. Gastroenterology in the Trent region in 1992 and a review of changes since 1975. Gut 1995;36:468-72.
16. Westbrook JI, Rushworth RL, Rob MI, Rubin GL. Diagnostic procedures and health outcomes. Upper gastrointestinal tract investigations in the elderly. Med J Aust 1993; 159:242-5.
17. Westbrook JI. Trends in the utilization of diagnostic upper GI endoscopy in New South Wales, Australia, 1988 to 1998. Gastrointest Endosc 2002;55:847-53.
18. Lassen A, Hallas J, Schaffalitzky de Muckadell OB. Use of antisecretory medication: a population-based cohort study. Aliment Pharmacol Ther 2004;20:577-583.
19. Loffeld RJ, van der Putten AB. Rising incidence of reflux oesophagitis in patients undergoing upper gastrointestinal endoscopy. Digestion 2003;68:141-4.
20. Sue-Ling HM, Johnston D, Martin IG, Dixon MF, Lansdown MR, McMahon MJ, et al. Gastric cancer: a curable disease in Britain. Br Med J 1993;307:591-6.
21. Hansen JM, Bytzer P, Schaffalitzky de Muckadell OB. Management of dyspeptic patients in primary care. Value of the unaided clinical diagnosis and of dyspepsia subgrouping. Scand J Gastroenterol 1998;33:799-805.
22. Bytzer P, Hansen JM, Havelund T, Malchow MA, Schaffalitzky de Muckadell OB. Predicting endoscopic diagnosis in the dyspeptic patient: the value of clinical judgement. Eur J Gastroenterol Hepatol 1996;8:359-63.
23. Lassen AT, Pedersen FM, Bytzer P, Schaffalitzky de Muckadell OB. Helicobacter pylon test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial. Lancet 2000;356:455-60.
24. Westbrook JI, Talley NJ. Diagnostic investigation rates and use of prescription and non-prescription medications amongst dyspeptics: a population-based study of 2300 Australians. Aliment Pharmacol Ther 2003;17:1171-8.
25. Jones R. What happens to patients with non-ulcer dyspepsia after endoscopy? Practitioner 1988;232:75-6, 78.
26. Hungin AP, Thomas PR, Bramble MG, Corbett WA, Idle N, Contractor BR, et al. What happens to patients following open access gastroscopy? An outcome study from general practice. Br J Gen Pract 1994;44:519-21.
27. Hansen JM, Bytzer P, Bondesen S, Schaffalitzky de Muckadell OB. Efficacy and outcome of an open access endoscopy service. Dan Med Bull 1991;38:288-90.